Prognostic variables are those estimations accessible at the hour of finding that are related with ailment free or by and large endurance and can regularly be utilized to anticipate the common history of the tumor. Enhancing treatment dependent on prognostic components assumes a significant job in the administration of female bosom disease. The standard prognostic factors as of now applied in new instances of bosom disease incorporate axillary lymph hub status, histologic subtype, tumor size, atomic evaluation, hormone receptor status, proportions of expansion, and sub-atomic markers, for example, HER2 overexpression. Of these, the nearness or nonappearance of metastatic carcinoma in the axillary lymph hubs is the most impressive prognostic factor for patients with essential bosom malignant growth. In male bosom malignancy, tumor size, and lymph hub contribution are two clear prognostic elements for male patients with bosom cancer.7 Men with tumors estimating 2–5 cm have a 40% higher danger of death than men with tumors <2 cm in most extreme diameter.7 Similarly, men with lymph hub association have a half higher danger of death than those without lymph hub involvement.7 There are various reports in male bosom disease that additionally correspond result with nodal inclusion.
Letter to Editor: Journal of Blood & Lymph
Letter to Editor: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Clinical image: Journal of Blood & Lymph
Clinical image: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Scientific Tracks Abstracts: Cardiovascular Diseases & Diagnosis
Scientific Tracks Abstracts: Cardiovascular Diseases & Diagnosis
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Journal of Blood & Lymph received 443 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 